Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06566599 · ClinicalTrials.gov registry record
Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Couples With Non-obstructive Azoospermia (NOA)
A clinical trial, sponsored by Inception Fertility Research Institute.
- Active
- Registry status
- 400
- Enrollment target
NCT06566599: Active study, sponsored by Inception Fertility Research Institute.
NCT06566599 is a clinical trial that is active but no longer recruiting, run by Inception Fertility Research Institute. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06566599 is active but no longer recruiting, sponsored by Inception Fertility Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 400 participants
- Enrollment target
Study Summary
Objective: To examine the rate of embryo aneuploidy in patients with non-obstructive azoospermia (NOA) who utilize in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) and compare live birth rates with the utilization of preimplantation genetic testing for aneuploidy (PGT-A) vs non PGT-A.
Primary Outcome
Frequency of aneuploidy result in embryos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2027-04 |
What the registry record for NCT06566599 still lists
NCT06566599 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06566599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06566599 about?
NCT06566599 is a clinical study titled "Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Couples With Non-obstructive Azoospermia (NOA)". Objective: To examine the rate of embryo aneuploidy in patients with non-obstructive azoospermia (NOA) who utilize in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) and compare live birth rates with the utilization of preimplantation genetic testing for aneuploidy (PGT-A) vs non P...
What is the current status of trial NCT06566599?
This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2024-08-19. Estimated completion is 2027-04.
Who is sponsoring clinical trial NCT06566599?
This trial is sponsored by Inception Fertility Research Institute, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI